Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02037802Completed
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection and fentanyl in kidney failure (ESRD) (2 arms), sponsored by Cairo University. Primary endpoint: Intraoperative blood pressure. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02037802.